Cadenza Bio
Oklahoma City · Founded 2022
About Cadenza Bio
Cadenza Bio accelerates and supports the development of a new class of highly selective Estrogen Receptor targeted small molecules. We are committed to developing therapeutic medications that will improve the lives of patients suffering from terrible diseases.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.9M
- Funding stage: Seed
- Last round: Debt Financing (Aug 2025)
- Website: https://www.cadenza.bio
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/cadenza-bio-112328 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.